Thrombosis research
-
Thrombosis research · Mar 2021
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
In the first wave, thrombotic complications were common in COVID-19 patients. It is unknown whether state-of-the-art treatment has resulted in less thrombotic complications in the second wave. ⋯ Mortality was reduced by 47% in the second wave, but the thrombotic complication rate remained high, and comparable to the first wave. Careful attention to provision of adequate thromboprophylaxis is invariably warranted.